Prevalence of iron deficiency and anemia in pediatric heart transplant recipients
Corresponding Author
David M. Newland
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Correspondence
David M. Newland, Department of Pharmacy, Seattle Children's Hospital, 4800 Sandpoint Way NE, Mailstop MB.5.420, Seattle, WA 98105, USA.
Email: [email protected]
Search for more papers by this authorKathryn L. Spencer
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
Search for more papers by this authorLong D. Do
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
Search for more papers by this authorLisa R. Knorr
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorMichelle M. Palmer
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorErin L. Albers
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorJoshua M. Friedland-Little
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorBorah J. Hong
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorMariska S. Kemna
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorChristina Hartje-Dunn
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorDominique G. Mark
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorThomas L. Nemeth
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorSara Ravi-Johnson
Clinical Nutrition, Seattle Children's Hospital, Seattle, Washington, USA
Search for more papers by this authorYuk M. Law
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorCorresponding Author
David M. Newland
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Correspondence
David M. Newland, Department of Pharmacy, Seattle Children's Hospital, 4800 Sandpoint Way NE, Mailstop MB.5.420, Seattle, WA 98105, USA.
Email: [email protected]
Search for more papers by this authorKathryn L. Spencer
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
Search for more papers by this authorLong D. Do
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
Search for more papers by this authorLisa R. Knorr
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorMichelle M. Palmer
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorErin L. Albers
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorJoshua M. Friedland-Little
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorBorah J. Hong
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorMariska S. Kemna
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorChristina Hartje-Dunn
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorDominique G. Mark
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorThomas L. Nemeth
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington, USA
School of Pharmacy, University of Washington, Seattle, Washington, USA
Search for more papers by this authorSara Ravi-Johnson
Clinical Nutrition, Seattle Children's Hospital, Seattle, Washington, USA
Search for more papers by this authorYuk M. Law
Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington, USA
School of Medicine, University of Washington, Seattle, Washington, USA
Search for more papers by this authorAbstract
Introduction
The prevalence of iron deficiency and anemia in the setting of modern-day maintenance immunosuppression in pediatric heart transplant (HTx) recipients is unclear. The primary aim was to determine the prevalence of iron deficiency (serum ferritin < 30 ng/mL ± transferrin saturation < 20%) and anemia per World Health Organization diagnostic criteria and associated risk factors.
Methods
Single-center, cross-sectional analysis of 200 consecutive pediatric HTx recipients (<21 years old) from 2005 to 2021. Data were collected at 1-year post-HTx at the time of annual protocol biopsy.
Results
Median age at transplant was 3 years (IQR .5–12.2). The median ferritin level was 32 ng/mL with 46% having ferritin < 30 ng/mL. Median transferrin saturation (TSAT) was 22% with 47% having TSAT < 20%. Median hemoglobin was 11 g/dL with 54% having anemia. Multivariable analysis revealed lower absolute lymphocyte count, TSAT < 20%, and estimated glomerular filtration rate <75 mL/min/1.73 m2 were independently associated with anemia. Ferritin < 30 ng/mL in isolation was not associated with anemia. Ferritin < 30 ng/mL may aid in detecting absolute iron deficiency while TSAT < 20% may be useful in identifying patients with functional iron deficiency ± anemia in pediatric HTx recipients.
Conclusion
Iron deficiency and anemia are highly prevalent in pediatric HTx recipients. Future studies are needed to assess the impact of iron deficiency, whether with or without anemia, on clinical outcomes in pediatric HTx recipients.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
Open Research
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Supporting Information
Filename | Description |
---|---|
ctr15367-sup-0001-SuppMat.docx28.8 KB | Supporting information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Safiri S, Kolahi AA, Noori M, et al. Burden of anemia and its underlying causes in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. J Hematol Oncol. 2021; 14(1): 185. doi:10.1186/s13045-021-01202-2
- 2McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009; 12(4): 444-454. doi:10.1017/S1368980008002401
- 3Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015; 372(19): 1832-1843. doi:10.1056/NEJMra1401038
- 4Szajewska H, Ruszczynski M, Chmielewska A. Effects of iron supplementation in nonanemic pregnant women, infants, and young children on the mental performance and psychomotor development of children: a systematic review of randomized controlled trials. Am J Clin Nutr. 2010; 91(6): 1684-1690. doi:10.3945/ajcn.2010.29191
- 5Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med. 1991; 325(10): 687-694. doi:10.1056/NEJM199109053251004
- 6Halterman JS, Kaczorowski JM, Aligne CA, Auinger P, Szilagyi PG. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics. 2001; 107(6): 1381-1386. doi:10.1542/peds.107.6.1381
- 7McCann JC, Ames BN. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr. 2007; 85(4): 931-945. doi:10.1093/ajcn/85.4.931
- 8Velleca A, Shullo MA, Dhital K, et al. The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2023; 42(5): e1-e141. doi:10.1016/j.healun.2022.10.015
- 9 Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009; 9(Suppl 3): S1-S157.
- 10Fenton M, Simmonds J, Shah V, et al. Inflammatory cytokines, endothelial function, and chronic allograft vasculopathy in children: an investigation of the donor and recipient vasculature after heart transplantation. Am J Transplant. 2016; 16(5): 1559-1568.
- 11Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell. 2010; 142(1): 24-38. doi:10.1016/j.cell.2010.06.028
- 12Ganz T. Hepcidin. Rinsho Ketsueki. 2016; 57(10): 1913-1917. doi:10.11406/rinketsu.57.1913
- 13Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016; 387(10021): 907-916. doi:10.1016/S0140-6736(15)60865-0
- 14Ning S, Zeller MP. Management of iron deficiency. Hematology Am Soc Hematol Educ Program. 2019; 2019(1): 315-322. doi:10.1182/hematology.2019000034
- 15Moscheo C, Licciardello M, Samperi P, La Spina M, Di Cataldo A, Russo G. New insights into iron deficiency anemia in children: a practical review. Metabolites. 2022; 12(4): 289. doi:10.3390/metabo12040289
- 16Brautaset Englund KV, Østby CM, Tjønnås G, et al. Prevalence of iron deficiency in heart transplant recipients. Clin Transplant. 2021; 35(8):e14346. doi:10.1111/ctr.14346. Epub 2021 May 28.
- 17Embleton ND, O'Sullivan JJ, Hamilton JR, Dark JH, Summerfield GP. High prevalence of anemia after cardiac transplantation in children. Transplantation. 1997; 64(11): 1590-1594. doi:10.1097/00007890-199712150-00015
- 18Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005; 24(11): 1710-1720. doi:10.1016/j.healun.2005.03.019. Epub 2005 Jun 20.
- 19 WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations [Internet]. Geneva: World Health Organization; 2020.
- 20 WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011. (WHO/NMH/NHD/MNM/11.1). Accessed March 23, 2023 http://www.who.int/vmnis/indicators/haemoglobin.pdf
- 21Kliger AS, Foley RN, Goldfarb DS, et al. KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis. 2013; 62(5): 849-859. doi:10.1053/j.ajkd.2013.06.008. Epub 2013 Jul 25.
- 22 Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for anemia in chronic kidney disease. Kidney Inter Suppl. 2012; 2: 279-335.
- 23Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145(18): e895-e1032. doi:10.1161/CIR.0000000000001063. Epub 2022 Apr 1. Erratum in: Circulation. 2022 May 3;145(18):e1033. Erratum in: Circulation. 2022 Sep 27;146(13):e185. Erratum in: Circulation. 2023 Apr 4;147(14):e674.
- 24Kirk R, Dipchand AI, Rosenthal DN, et al. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary. J Heart Lung Transplant. 2014; 33(9): 888-909. doi:10.1016/j.healun.2014.06.002. Epub 2014 Jun 17. Erratum in: J Heart Lung Transplant. 2014 Oct;42(5):1104.
- 25Spinner JA, Denfield SW. Immunosuppressant drugs and their effects on children undergoing solid organ transplant. Pediatr Rev. 2022; 43(2): 71-86. doi:10.1542/pir.2020-000620
- 26Brautaset Englund KV, Østby CM, Rolid K, et al. Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): a randomized clinical trial. J Heart Lung Transplant. 2021; 40(5): 359-367. doi:10.1016/j.healun.2021.01.1390
- 27Newland DM, Pak JL, Ali R, et al. Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients. Clin Transplant. 2023; 37(11):e15087. doi:10.1111/ctr.15087
- 28VanSickle JS, Warady BA. Chronic kidney disease in children. Pediatr Clin North Am. 2022; 69(6): 1239-1254. doi:10.1016/j.pcl.2022.07.010. Epub 2022 Oct 29.
- 29Atkinson MA, Warady BA. Anemia in chronic kidney disease. Pediatr Nephrol. 2018; 33(2): 227-238. doi:10.1007/s00467-017-3663-y
- 30Przybylowski P, Malyszko J, Malyszko J. Anemia is a predictor of outcome in heart transplant recipients. Transplant Proc. 2009; 41(8): 3228-3231. doi:10.1016/j.transproceed.2009.07.076
- 31Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352: 1011-1023.
- 32Goland S, Czer LS, Coleman B, et al. Induction therapy with thymoglobulin after heart transplantation: impact of therapy duration on lymphocyte depletion and recovery, rejection, and cytomegalovirus infection rates. J Heart Lung Transplant. 2008; 27(10): 1115-1121. doi:10.1016/j.healun.2008.07.002
- 33Van Vranken M. Evaluation of microcytosis. Am Fam Physician. 2010; 82(9): 1117-1122. Erratum in: Am Fam Physician. 2011 Apr 1;83(7):792.
- 34Litao MKS, Kamat D. Back to basics: red blood cell distribution width: clinical use beyond hematology. Pediatr Rev. 2018; 39(4): 204-209. doi:10.1542/pir.2017-0118